1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PFIZER INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Drug pricing issues.

LobbyistCovered position, as disclosed
STEVEN CHAMPLIN —
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Comprehensive tax reform. International tax policy, including inversions.

LobbyistCovered position, as disclosed
STEVEN CHAMPLIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Trans Pacific Partnership (TPP) negotiations - Executive Branch action re this issue. Miscellaneous tariff bill. Customs reauthorization conference report - HR 644, Trade Facilitation and Trade Enforcement Act of 2015.

LobbyistCovered position, as disclosed
STEVEN CHAMPLIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 644 (114th)

Health Issues HCR

21st Century Cures - HR 6, 21st Century Cures Act. Budget resolution and fiscal issues affecting healthcare.

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

Medicare reimbursement rates.

LobbyistCovered position, as disclosed
STEVEN CHAMPLIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.